~ Jun 09 Physician's Guide: Using Blood Test Findings To Safely Induce Weight Loss - References

References

1. Curr Hypertens Rep. 2008 Feb;10(1):32-8.

2. Lancet. 2005 Apr 16;365(9468):1415-28.

3. Diabetes. 1996 Jul;45(Suppl 3):S59-61.

4. J Nutr Biochem. 2008 Aug;19(8):491-504.

5. Am J Physiol Heart Circ Physiol. 2007 Feb;292(2):H904-11.

6. Nutr Rev. 2007 Dec;65(12 Pt 2):S253-9.

7. Prev Med. 2006 May;42(5):336-42.

8. Acta Physiol Scand. 2005 Aug;184(4):285-93.

9. Curr Atheroscler Rep. 2004 Nov;6(6):424-31.

10. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2466139.

11. JAMA. 2002 Dec 4;288(21):2709-16.

12. Int J Obes Relat Metab Disord. 1996 Apr;20(4):291-302.

13. Med Sci (Paris). 2005 Dec;21 Spec No10-8.

14. Metab Syndr Relat Disord. 2008 Winter;6(4):299-304.

15. Obes Rev. 2009 Mar;10(Suppl 1):24-33.

16. http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601244.html.

17. Am J Clin Nutr. 2007 Jun;85(6):1511-20.

18. Clin Ther. 2005;27(Suppl B):S42-56.

19. http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B83WG-4S1C3S2-6&_user=10&_rdoc=1&_fmt=& _orig=search&_ sort=d&view=c&_acct=C000050221& _version=1&_urlVersion=0& _userid=10&md5=36aa01bb7107426818b8e8747f3cf0aa.

20. Stroke. 2004 May;35(5):1073-8.

21. Eur Heart J. 2004 Jan;25(1):10-6.

22. Int J Cardiol. 2006 Feb 8;107(1):11-20.

23. Aronson JK. Meyler's Side Effects of Endocrine and Metabolic Drugs. New York, NY: Elsevier Science; 2008:361.

24. Curr Diabetes Rev. 2008 Nov;4(4):340-56.

25. Nutrition. 2005 Jul-Aug;21(7-8):848-54.

26. Altern Med Rev. 2004 Mar;9(1):63-9.

27. JAMA. 2007 Jul 18;298(3):299-308.

28. J Am Diet Assoc. 1998 Oct;98(10 Suppl 2):S23-6.

29. Drugs Today (Barc). 1999 Feb;35(2):139-45.

30. Prim Care. 2003 Jun;30(2):427-40.

31. Obesity (Silver Spring). 2008 Mar;16(3):623-9.

32. Arch Intern Med. 2007 May 14;167(9):893-902.

33. FASEB J. 2000 Jun;14(9):1132-8.

34. Obes Surg. 1993 Nov;3(4):421-4.

35. Curr Atheroscler Rep. 2003 Nov;5(6):445-51.

36. Appl Physiol Nutr Metab. 2007 Jun;32(3):473-80.

37. Drugs. 2006;66(12):1625-56.

38. Obes Res. 2000 Jan;8(1):49-61.

39. Arq Bras Cardiol. 2007 Dec;89(6):409-14.

40. Hormones (Athens). 2006 Oct;5(4):259-69.

41. Am J Cardiol. 2003 Apr 15;91(8):961-4.

42. Angiology. 2007 Feb;58(1):26-33.

43. Eat Weight Disord. 2006 Mar;11(1):e35-41.

44. Metab Syndr Relat Disord. 2005;3(2):122-9.

45. Arterioscler Thromb Vasc Biol. 1995 Dec;15(12):2111-21.

46. Am J Clin Nutr. 2006 Dec;84(6):1290-8.

47. Ir J Med Sci. 2005 Jan-Mar;174(1):8-20.

48. Am J Clin Nutr. 2003 Mar;77(3):605-11.

49. Curr Opin Lipidol. 2002 Feb;13(1):33-40.

50. J Am Coll Nutr. 2000 Jun;19(3):383-91.

51. J Nutr. 2002 Jul;132(7):1879-85.

52. J Nutr. 2005 Jun;135(6):1339-42.

53. J Nutr. 2004 Apr;134(4):880-5.

54. Am J Clin Nutr. 2003 Feb;77(2):300-7.

55. Am J Clin Nutr. 2000 Apr;71(4):914-20.

56. Nutr Metab Cardiovasc Dis. 2001 Feb;11(1):7-16.

57. Atherosclerosis. 2006 Apr;185(2):313-9.

58. Br J Nutr. 2005 Apr;93(4):543-7.

59. Sports Med. 2006;36(7):547-60.

60. Arch Intern Med. 2000 Apr 24;160(8):1177-84.

61. Am J Cardiol. 2000 May 1;85(9):1100-5.

62. Diabetes Care. 2005 Apr;28(4):844-9.

63. Metabolism. 1998 Apr;47(4):371-6.

64. Diabetologia. 2006 Mar;49(3):527-37.

65. Exp Clin Endocrinol Diabetes. 2005 Feb;113(2):80-4.

66. Am J Cardiol. 2004 Jan 1;93(1):31-9.

67. Atherosclerosis. 2004 Feb;172(2):375-82.

68. Chin Med J (Engl). 2003 Mar;116(3):453-8.

69. Am J Med. 1997 Jan;102(1):99-110.

70. Advances in Therapy. 1997 Jan 1;14(6):338–47.

71. Drugs. 1999;58(Suppl 1):71-3.

72. Diabetes Care. 2001 Mar;24(3):489-94.

73. Biochem Biophys Res Commun. 2002 Nov 15;298(5):779-84.

74. Obes Rev. 2004 Nov;5(4):197-216.

75. Eur Heart J. 2002 May;23(9):706-13.

76. Circulation. 2008 Apr 1;117(13):1658-67.

77. J Endocrinol Invest. 2006;29(3 Suppl):77-82.

78. http://www.cancer.gov/cancertopics/factsheet/risk/obesity.

79. J Natl Cancer Inst. 2006 Jul 5;98(13):920-31.

80. Int J Obes Relat Metab Disord. 2002 Jun;26(6):747-53.

81. Curr Urol Rep. 2007 Nov;8(6):467-71.

82. Curr Opin Endocrinol Diabetes Obes. 2007 Jun;14(3):226-34.

83. Maturitas. 2008 May 20;60(1):10-8.

84. J Clin Endocrinol Metab. 2008 Jan;93(1):139-46.

85. J Clin Endocrinol Metab. 1995 Jan;80(1):239-43.

86. Clin Endocrinol (Oxf). 2005 Sep;63(3):239-50.

87. Int J Obes Relat Metab Disord. 2000 Apr;24(4):485-91.

88. Obes Res. 1995 Nov;3(Suppl 4):609S-12S.

89. J Clin Endocrinol Metab. 2001 Aug;86(8):3604-10.

90. Int J Obes Relat Metab Disord. 1995 Sep;19(9):614-24.

91. Metabolism. 1997 Feb;46(2):179-85.

92. J Clin Endocrinol Metab. 2006 Jun;91(6):1995-2010.

93. Cancer Epidemiol Biomarkers Prev. 1996 Aug;5(8):621-5.

94. Psychosom Med. 2000 Sep;62(5):623-32.

95. Metabolism. 1992 Aug;41(8):882-6.

96. Metabolism. 1980 Oct;29(10):980-5.

97. J Clin Endocrinol Metab. 1990 Feb;70(2):473-9.

98. J Clin Invest. 1988 Sep;82(3):1106-12.

99. J Clin Invest. 1982 May;69(5):1119-25.

100. Am J Obstet Gynecol. 1998 Jan;178(1 Pt 1):101-7.

101. J Clin Endocrinol Metab. 1995 Mar;80(3):936-41.

102. Am J Epidemiol. 2008 May 15;167(10):1207-16.

103. JAMA. 2008 Mar 5;299(9):1036-45.

104. J Steroid Biochem Mol Biol. 2008 Feb;108(3-5):272-80.

105. Obesity (Silver Spring). 2009 Jan 29.

106. J Clin Endocrinol Metab. 2006 Oct;91(10):3970-80.

107. Hum Reprod. 2003 Jan;18(1):57-60.

108. Clin Endocrinol (Oxf). 2004 Feb;60(2):241-9.

109. J Fam Pract. 1994 Jun;38(6):577-82.

110. Thyroid. 1998 Sep;8(9):803-13.

111. Kasper DL, Braunwald E, Hauser SL, Longo DL, Jameson JL. Harrison's Principles of Internal Medicine. 16th ed. New York, NY: McGraw-Hill Professional; 2004.

112. Metabolism. 1976 Jan;25(1):79-83.

113. J Clin Endocrinol Metab. 1977 Oct;45(4):707-13.

114. J Endocrinol. 1989 Feb;120(2):337-50.

115. Int J Obes. 1990 Mar;14(3):249-58.

116. N Engl J Med. 1979 Mar 15;300(11):579-84.

117. Trans Assoc Am Physicians. 1978;91:169-79.

118. Metabolism. 1975 Oct;24(10):1177-83.

119. Int J Obes. 1989;13(4):487-96.

120. J Clin Endocrinol Metab. 1996 Mar;81(3):968-76.

121. Clin Endocrinol (Oxf). 1984 Oct;21(4):357-67.

122. Thyroid. 2008 Feb;18(2):197-203.

123. Nat Med. 2006 Apr;12(4):425-32.

124. Lipids Health Dis. 2009;87.

125. Lipids Health Dis. 2005 May 25;412.

126. Lipids Health Dis. 2008;744.

127. Acta Cardiol. 2005 Jun;60(3):265-9.

128. J Clin Endocrinol Metab. 2003 Oct;88(10):4649-54.

129. Obesity (Silver Spring). 2008 Jul;16(7):1573-8.

130. Horm Metab Res. 2008 Mar;40(3):199-205.

131. J Am Coll Cardiol. 2004 Jul 7;44(1):152-8.

132. JAMA. 2003 Jul 23;290(4):502-10.

133. J Am Coll Nutr. 2008 Jun;27(3):434-40.

134. Am J Cardiol. 2006 Sep 15;98(6):743-5.

135. QJM. 2002 Dec;95(12):787-96.

136. Am J Epidemiol. 2008 Feb 1;167(3):313-20.

137. Thromb Res. 2008;122(1):125-33.

138. Surgery. 2005 Aug;138(2):212-22.

139. J Thromb Haemost. 2007 Jun;5(6):1309-17.

140. J Nutr. 2008 Oct;138(10):1939-45.

141. WG0401 protective against generalized inflammation in a human study. Unpublished data; WellGen, Inc.; 2007.

142. N Engl J Med. 1996 Jan 25;334(4):269-70.

143. Drugs. 1999;58(Suppl 1):71-3.

144. Obes Res. 1998 Jan;6(1):47-53.

145. Intern Med. 2008;47(8):697-703.

146. Clin Exp Pharmacol Physiol. 2008 Aug;35(8):895-903.

147. Obes Res. 2001 Nov;9(11):662-7.

148. Curr Hypertens Rep. 2008 Apr;10(2):131-7.

149. Front Biosci. 2007;12:3531-44.

150. Obesity (Silver Spring). 2006 Aug;14(Suppl 5):254S-8S.

151. Endocr J. 2008 Oct;55(5):827-37.

152. Exp Biol Med (Maywood). 2005 Mar;230(3):200-6.

153. FASEB J. 2001 Feb;15(2):333-40.

154. J Consult Clin Psychol. 2003 Dec;71(6):1084-9.

155. J Clin Psychopharmacol. 2006 Aug;26(4):409-13.

156. Prague Med Rep. 2005;106(3):291-6.

157. Clin Ther. 2006 Feb;28(2):266-79.

158. Eur J Pharmacol. 2000 May 26;397(1):93-102.

159. Int J Obes Relat Metab Disord. 1998 Aug;22(Suppl 1):S18-28.

160. http://www.fda.gov/cder/foi/label/2006/020632s026lbl.pdf.

161. http://www.cdc.gov/nchs/FASTATS/deaths.htm.

162. http://www.cancer.org/docroot/PED/content/PED_10_2X_Cigarette_Smoking.asp.

163. JAMA. 2004 Mar 10;291(10):1238-45.


Free Shipping in the Continental U.S. on Orders over $50
The statements made here have not been evaluated by the FDA. The foregoing statements are based upon sound and reliable studies, and are meant for informational purposes. Consult with your medical practitioner to determine the underlying cause of your symptoms. Please always check your purchase for possible allergins and correct dosage on the bottle before use.

While we work to ensure that product information is correct, on occasion manufacturers may alter their ingredient lists. Actual product packaging and materials may contain more and/or different information than that shown on our Web site. We recommend that you do not solely rely on the information presented and that you always read labels, warnings, and directions before using or consuming a product. For additional information about a product, please contact the manufacturer. Content on this site is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional. You should not use this information as self-diagnosis or for treating a health problem or disease. Contact your health-care provider immediately if you suspect that you have a medical problem. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or health condition. Life Ex Online assumes no liability for inaccuracies or misstatements about products.